oxcarbazepine has been researched along with lacosamide in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (61.11) | 24.3611 |
| 2020's | 7 (38.89) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fadda, V; Giovannelli, F; Maratea, D; Verrotti, A; Zaccara, G | 1 |
| Bonifácio, MJ; Hebeisen, S; Loureiro, AI; Palma, N; Pires, N; Soares-da-Silva, P; Spanswick, D; Whyment, A | 1 |
| Horváth, A; Kamondi, A; Szűcs, A | 1 |
| Kumar, D; Laurenza, A; Meador, KJ; Piña-Garza, JE; Wesnes, KA; Yang, H | 1 |
| Andres-Mach, M; Florek-Łuszczki, M; Patrzylas, P; Pyrka, D; Skalicka-Woźniak, K; Szpringer, M; Zagaja, M; Żółkowska, D; Łuszczki, JJ | 1 |
| Chan, EL; Chan, I; Chang, RS; Fong, GC; Fong, JK; Fung, BB; Fung, EL; Leung, H; Lui, CH; Poon, TL; Siu, D; Wong, HT; Yeung, E; Yung, AW; Zhu, CX | 1 |
| Alfano, G; Mangiardi, M | 1 |
| Nieoczym, D; Socała, K; Szafarz, M; Wlaź, P; Wyska, E | 1 |
| Kaimovsky, IL; Mkrtchyan, VR | 1 |
| Feng, J; Li, HJ; Ma, L; Sun, L; Sun, Y; Wang, TT; Yu, J; Yu, LH; Zhao, T | 1 |
| Bialer, M; Franco, V; Odi, R; Perucca, E | 1 |
| Bojar, H; Florek-Łuszczki, M; Marzęda, P; Plewa, Z; Wróblewska-Łuczka, P; Załuska-Ogryzek, K; Zolkowska, D; Łuszczki, JJ | 1 |
| Bromley, RL; Knight, R; Wittkowski, A | 1 |
| Birnbaum, AK; Gerard, E; Kalayjian, L; Karanam, A; Matthews, A; McElrath, TM; Meador, KJ; Pennell, PB; Penovich, P | 1 |
| Kumar, V; Panda, PK; Sharawat, IK; Sherwani, P | 1 |
| Battino, D; Bromley, R; Kochen, S; Meador, KJ; Pennell, PB; Thomas, SV; Tomson, T | 1 |
6 review(s) available for oxcarbazepine and lacosamide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
Topics: Acetamides; Anticonvulsants; Ataxia; Carbamazepine; Dibenzazepines; Diplopia; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Lacosamide; Nervous System Diseases; Oxcarbazepine; Randomized Controlled Trials as Topic; Risk Assessment; Sodium Channel Blockers; Treatment Outcome | 2013 |
An update of the Hong Kong Epilepsy Guideline: consensus statement on the use of antiepileptic drugs in Hong Kong.
Topics: Acetamides; Anticonvulsants; Carbamazepine; Consensus; Drugs, Generic; Epilepsy; Hong Kong; Humans; Lacosamide; Lamotrigine; Levetiracetam; Oxcarbazepine; Piracetam; Practice Guidelines as Topic; Societies, Medical; Triazines | 2017 |
Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in Europe.
Topics: Anticonvulsants; Area Under Curve; Biological Variation, Individual; Dibenzazepines; Drug Substitution; Drugs, Generic; Europe; Gabapentin; Humans; Lacosamide; Lamotrigine; Levetiracetam; Oxcarbazepine; Pregabalin; Therapeutic Equivalency; Topiramate; Vigabatrin; Zonisamide | 2021 |
Neurodevelopmental outcomes in children exposed to newer antiseizure medications: A systematic review.
Topics: Anticonvulsants; Child; Female; Gabapentin; Humans; Lacosamide; Lamotrigine; Levetiracetam; Oxcarbazepine; Pregnancy; Topiramate; Zonisamide | 2021 |
Breastfeeding while on treatment with antiseizure medications: a systematic review from the ILAE Women Task Force
Topics: Breast Feeding; Cannabidiol; Carbamazepine; Child; Clobazam; Clonazepam; Epilepsy; Ethosuximide; Everolimus; Felbamate; Female; Fenfluramine; Gabapentin; Humans; Infant; Lacosamide; Lamotrigine; Levetiracetam; Oxcarbazepine; Phenobarbital; Phenytoin; Prospective Studies; Tiagabine; Topiramate; Valproic Acid; Vigabatrin; Zonisamide | 2022 |
2 trial(s) available for oxcarbazepine and lacosamide
| Article | Year |
|---|---|
Cognitive effects of adjunctive perampanel for partial-onset seizures: A randomized trial.
Topics: Acetamides; Adolescent; Anticonvulsants; Attention; Carbamazepine; Child; Cognition; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Female; Fructose; Humans; Lacosamide; Lamotrigine; Levetiracetam; Male; Memory, Short-Term; Neuropsychological Tests; Nitriles; Oxcarbazepine; Piracetam; Pyridones; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2016 |
A clinical efficacy experience of Lacosamide on sleep quality in patients with Nocturnal Frontal Lobe Epilepsy (NFLE).
Topics: Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Substitution; Epilepsy, Frontal Lobe; Female; Humans; Lacosamide; Male; Nocturnal Paroxysmal Dystonia; Oxcarbazepine; Voltage-Gated Sodium Channel Blockers | 2018 |
10 other study(ies) available for oxcarbazepine and lacosamide
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide.
Topics: Acetamides; Animals; Anticonvulsants; Carbamazepine; Cell Line, Tumor; Dibenzazepines; Dose-Response Relationship, Drug; Hippocampus; Lacosamide; Male; Mice; Organ Culture Techniques; Oxcarbazepine; Time Factors; Voltage-Gated Sodium Channels | 2015 |
[The efficacy of lacosamide in relation to antiepileptic drug history. Clinical experiences in adult partial epilepsy].
Topics: Acetamides; Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Drug Resistance; Drug Therapy, Combination; Epilepsies, Partial; Female; Follow-Up Studies; Humans; Lacosamide; Male; Middle Aged; Oxcarbazepine; Recurrence; Retrospective Studies; Treatment Outcome | 2015 |
Influence of xanthotoxin (8-methoxypsoralen) on the anticonvulsant activity of various novel antiepileptic drugs against maximal electroshock-induced seizures in mice.
Topics: Acetamides; Animals; Anticonvulsants; Carbamazepine; Drug Synergism; Electroshock; Fructose; Lacosamide; Lamotrigine; Male; Methoxsalen; Mice; Oxcarbazepine; Pregabalin; Seizures; Topiramate; Triazines | 2016 |
Acute effect of cannabidiol on the activity of various novel antiepileptic drugs in the maximal electroshock- and 6 Hz-induced seizures in mice: Pharmacodynamic and pharmacokinetic studies.
Topics: Animals; Anticonvulsants; Brain; Cannabidiol; Chromatography, High Pressure Liquid; Disease Models, Animal; Drug Interactions; Drug Resistant Epilepsy; Electric Stimulation; Gabapentin; Lacosamide; Lamotrigine; Levetiracetam; Male; Mice; Oxcarbazepine; Pregabalin; Seizures; Tiagabine; Topiramate | 2019 |
[Pharmacoeconomic aspects of monotherapy of focal epilepsy].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Cost-Benefit Analysis; Economics, Pharmaceutical; Epilepsies, Partial; Humans; Lacosamide; Lamotrigine; Oxcarbazepine; Retrospective Studies | 2019 |
Development and validation of an innovative UPLC method to quantify lacosamide, oxcarbazepine, and lamotrigine in the serum of children with epilepsy in China.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; China; Chromatography, High Pressure Liquid; Epilepsy; Humans; Infant; Lacosamide; Lamotrigine; Limit of Detection; Linear Models; Oxcarbazepine; Reproducibility of Results | 2021 |
Interactions among Lacosamide and Second-Generation Antiepileptic Drugs in the Tonic-Clonic Seizure Model in Mice.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Electroshock; Epilepsy; Lacosamide; Lamotrigine; Male; Mice; Oxcarbazepine; Pregabalin; Seizures; Topiramate | 2021 |
Antiseizure Medication Concentrations During Pregnancy: Results From the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) Study.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Lacosamide; Lamotrigine; Levetiracetam; Oxcarbazepine; Pregnancy; Prospective Studies; Topiramate; Zonisamide | 2022 |
Comparative Efficacy and Safety of Lacosamide and Oxcarbazepine for Seizure Control in Children with Newly Diagnosed Solitary Neurocysticercosis.
Topics: Anticonvulsants; Child; Epilepsies, Partial; Female; Humans; Lacosamide; Levetiracetam; Male; Neurocysticercosis; Oxcarbazepine; Seizures; Treatment Outcome | 2022 |